Lars Køber
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes Treatment and Management
Papers in
-
- Heart Failure Treatment and Management 401
- Acute Myocardial Infarction Research 211
- Atrial Fibrillation Management and Outcomes 147
- Cardiovascular Function and Risk Factors 107
- Cardiac Valve Diseases and Treatments 83
-
- Cardiac Arrest and Resuscitation 92
- Co-authors
- Christian Tobias Torp-Pedersen (251 shared papers)Gunnar Gislason (251 shared papers)John J.V. McMurray (199 shared papers)Scott David Solomon (172 shared papers)Emil Loldrup Fosbøl (251 shared papers)Marc Alan Pfeffer (73 shared papers)Aldo Pietro Maggioni (48 shared papers)Eric J. Velazquez (36 shared papers)
- Journals
- European Heart Journal (131 papers)European Journal of Heart Failure (125 papers)Journal of the American College of Cardiology (88 papers)Circulation (79 papers)International Journal of Cardiology (69 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Lars Køber
1.5k papers receiving 103.6k citations
Lars Køber's Hit Papers
Peers
Comparison fields: 5 of 189
- Cardiology and Cardiovascular Medicine 61.4k
- Endocrinology, Diabetes and Metabolism 13.4k
- Emergency Medicine 6k
- Nephrology 4k
- Geriatrics and Gerontology 975
Countries citing papers authored by Lars Køber
This map shows the geographic impact of Lars Køber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Køber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Køber more than expected).
Fields of papers citing papers by Lars Køber
This network shows the impact of papers produced by Lars Køber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Køber. The network helps show where Lars Køber may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Køber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.6k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 Hit paper breakdown → | 2012 | 5773 |
| 2 | Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Hit paper breakdown → | 2019 | 5268 |
| 3 | ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 Hit paper breakdown → | 2012 | 2290 |
| 4 | Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest Hit paper breakdown → | 2013 | 2091 |
| 5 | Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome Hit paper breakdown → | 2015 | 1959 |
| 6 | Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both Hit paper breakdown → | 2003 | 1946 |
| 7 | Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction Hit paper breakdown → | 2004 | 1623 |
| 8 | 2023 ESC Guidelines for the management of cardiomyopathies Hit paper breakdown → | 2023 | 1503 |
| 9 | 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Hit paper breakdown → | 2023 | 1460 |
| 10 | Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2018 | 1445 |
| 11 | A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction Hit paper breakdown → | 1995 | 1410 |
| 12 | 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Hit paper breakdown → | 2024 | 1394 |
| 13 | 2024 ESC Guidelines for the management of chronic coronary syndromes Hit paper breakdown → | 2024 | 1372 |
| 14 | Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure Hit paper breakdown → | 2016 | 1328 |
| 15 | Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials Hit paper breakdown → | 2019 | 1316 |
| 16 | Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients Hit paper breakdown → | 2000 | 1196 |
| 17 | 2024 ESC Guidelines for the management of elevated blood pressure and hypertension Hit paper breakdown → | 2024 | 1135 |
| 18 | Targeted Anticytokine Therapy in Patients With Chronic Heart Failure Hit paper breakdown → | 2004 | 1057 |
| 19 | Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies Hit paper breakdown → | 2012 | 1039 |
| 20 | Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE Hit paper breakdown → | 2012 | 994 |
About Lars Køber
Lars Køber is a scholar working on Cardiology and Cardiovascular Medicine, Emergency Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 1.6k papers that have together received 108.8k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (401 papers), Acute Myocardial Infarction Research (211 papers), Atrial Fibrillation Management and Outcomes (147 papers), Cardiovascular Function and Risk Factors (107 papers), Cardiac Arrest and Resuscitation (92 papers), Cardiac Imaging and Diagnostics (85 papers), Cardiac Valve Diseases and Treatments (83 papers) and Infective Endocarditis Diagnosis and Management (70 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (61.4k citations), Endocrinology, Diabetes and Metabolism (13.4k citations), Emergency Medicine (6k citations), Nephrology (4k citations) and Geriatrics and Gerontology (975 citations). Lars Køber has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Christian Tobias Torp-Pedersen, Gunnar Gislason, John J.V. McMurray, Scott David Solomon, Emil Loldrup Fosbøl, Marc Alan Pfeffer, Aldo Pietro Maggioni, Eric J. Velazquez, Jean Lucien Rouleau and Karl B Swedberg. Their work appears in journals such as European Heart Journal, European Journal of Heart Failure, Journal of the American College of Cardiology, Circulation and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.